Impact of Inhibition of the Mitochondrial Pyruvate Carrier on the Tumor Extracellular pH as Measured by CEST-MRI
(1) Background: The acidosis of the tumor micro-environment may have profound impact on cancer progression and on the efficacy of treatments. In the present study, we evaluated the impact of a treatment with UK-5099, a mitochondrial pyruvate carrier (MPC) inhibitor on tumor extracellular pH (pHe); (...
Main Authors: | Chloé Buyse, Nicolas Joudiou, Cyril Corbet, Olivier Feron, Lionel Mignion, Julien Flament, Bernard Gallez |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/17/4278 |
Similar Items
-
Mitochondrial Pyruvate Carrier Function in Health and Disease across the Lifespan
by: Jane L. Buchanan, et al.
Published: (2020-08-01) -
Targeting the Mitochondrial Pyruvate Carrier for Neuroprotection
by: Bor Luen Tang
Published: (2019-09-01) -
Experimental Investigations on the Structure of Yeast Mitochondrial Pyruvate Carriers
by: Ling Li, et al.
Published: (2022-09-01) -
The mitochondrial pyruvate carrier mediates high fat diet-induced increases in hepatic TCA cycle capacity
by: Adam J. Rauckhorst, et al.
Published: (2017-11-01) -
Stem Cell Metabolism in Cancer and Healthy Tissues: Pyruvate in the Limelight
by: Cyril Corbet
Published: (2018-01-01)